Publicaciones en colaboración con investigadores/as de Centro de Investigación en Red en Enfermedades Cardiovasculares (24)

2025

  1. Association between global myocardial work index and outcomes in nonischemic dilated cardiomyopathy

    Journal of cardiovascular medicine (Hagerstown, Md.), Vol. 26, Núm. 10, pp. 547-551

2023

  1. Current heart failure disease management and treatment in accredited units from cardiology and internal medicine in Spain

    Revista Clinica Espanola, Vol. 223, Núm. 7, pp. 405-413

2022

  1. Aging-related ILK levels are associated with calcified aortic valve and circulating miR 199-3p levels

    Revista Espanola de Cardiologia, Vol. 75, Núm. 1, pp. 88-91

  2. Challenges in managing patients with heart failure with reduced ejection fraction

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 1-7

  3. Role of vericiguat in the overall etiopathogenesis of heart failure with reduced ejection fraction. Current position

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 8-14

  4. Therapeutic approach to patients with heart failure with reduced ejection fraction. The role of vericiguat

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 23-29

  5. Vericiguat: VICTORIA trial results

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 15-22

2021

  1. Comparison between CA125 and NT-proBNP for evaluating congestion in acute heart failure

    Medicina Clinica, Vol. 156, Núm. 12, pp. 589-594

  2. Iron deficiency and short-term adverse events in patients with decompensated heart failure

    Clinical Research in Cardiology, Vol. 110, Núm. 8, pp. 1292-1298

  3. Ivabradine induces cardiac protection by preventing cardiogenic shock-induced extracellular matrix degradation

    Revista Espanola de Cardiologia, Vol. 74, Núm. 12, pp. 1063-1072

  4. Latest developments in 3D echocardiography. A novel tissue transparency tool

    Revista Espanola de Cardiologia, Vol. 74, Núm. 8, pp. 708

  5. Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48

  6. Mid-term Prognostic Implication of hospitalized COVID-19 patients with Prior Heart Failure diagnosis

    European Journal of Internal Medicine

2020

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)

    European Heart Journal, Vol. 41, Núm. 4, pp. 543-603

  2. A genetic risk score predicts recurrent events after myocardial infarction in young adults

    Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 623-631

  3. Beta-blocker effect on ST-segment: A prespecified analysis of the EARLY-BAMI randomised trial

    Open Heart, Vol. 7, Núm. 2

  4. Easy and self-administered questionnaire for frailty assessment in a community heart failure unit

    REC: CardioClinics, Vol. 55, Núm. 4, pp. 252-254

  5. Gender differences in health-related quality of life in patients with systolic heart failure: Results of the vida multicenter study

    Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-15

  6. Heart Failure in the Time of COVID-19

    Cardiology (Switzerland), Vol. 145, Núm. 8, pp. 481-484

  7. Myocardial injury determination improves risk stratification and predicts mortality in covid-19 patients

    Cardiology Journal, Vol. 27, Núm. 5, pp. 489-496